SCHEMBL6790781

SCHEMBL6790781

COc1cc(C(C)(C)C)ccc1/C=C/C=C/C(=O)N1CCCN(C(=O)/C=C/C=C/c2ccc(C(C)(C)C)cc2OC)CC1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.51
ALDH1A1 P00352 6/20 0.49
KMT2A Q03164 4/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
MEN1 O00255 3/20 0.49
MAPT P10636 3/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
KDM4E B2RXH2 4/20 0.47
TRPV1 Q8NER1 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 2/20 0.43
HTT P42858 1/20 0.42
PTGS2 P35354 2/20 0.42
ALOX5 P09917 2/20 0.42
MAOB P27338 1/20 0.42
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6793463 0.96 HPGD (0.48) HPGDALDH1A1KMT2ASMN1; SMN2MEN1
SCHEMBL5572652 0.88 TDP1 (0.44) HPGDALDH1A1KMT2ASMN1; SMN2MEN1
SCHEMBL5572648 0.88 TDP1 (0.44) HPGDALDH1A1KMT2ASMN1; SMN2MEN1
Hydrochloric Acid SCHEMBL7261682 0.87 TDP1 (0.43) HPGDL3MBTL1TDP1
Hydrochloric Acid SCHEMBL7261675 0.87 TDP1 (0.43) HPGDL3MBTL1TDP1
SCHEMBL6785525 0.84 MAPT (0.60) HPGDALDH1A1KMT2ASMN1; SMN2MEN1
SCHEMBL6788915 0.80 HPGD (0.78) HPGDALDH1A1KMT2ASMN1; SMN2MEN1
SCHEMBL4641354 0.80 ALDH1A1 (0.46) HPGDALDH1A1KMT2ASMN1; SMN2MEN1
SCHEMBL5573145 0.80 ALDH1A1 (0.46) HPGDALDH1A1KMT2ASMN1; SMN2MEN1
SCHEMBL6785546 0.80 HPGD (0.54) HPGDALDH1A1KMT2ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828316-B2 Antiallergens KOWA CO., LTD. (JP) 2004-12-07 US disclosed
US-20020042414-A1 Diamide compound and medicine containing the same KOWA CO., LTD. (JP) 2002-04-11 US disclosed
US-6340682-B1 FOR THERAPY OF ALLERGIC IMMUNOLOGICAL DISEASE IS SELECTED FROM ASTHMA, ALLERGIC RHINITIS, INFLAMMATORY LARGE BOWEL DISEASE OR CONTACT DERMATITIS KOWA CO., LTD. (JP) 2002-01-22 US disclosed
EP-0926138-A1 DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME KOWA CO. LTD. (JP) 1999-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042414-A1 Diamide compound and medicine containing the same HRH4, HRH2, HRH1 HPGD 884/4885ALDH1A1 836/4885KMT2A 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.